SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-03-002018
Filing Date
2003-03-27
Accepted
2003-03-27 16:31:31
Documents
10
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b45648ane10vk.htm 10-K 736332
3 EX-10.4 FORM OF INDEMNIFICATION AGREEMENT b45648anexv10w4.txt EX-10.4 706
4 AMENDMENT OF FOUNDING SCIENTIST b45648anexv10w29.txt EX-10.29 2401
5 EX-10.30 AMENDMENT #1 OF RESEARCH AGREEMENT b45648anexv10w30.txt EX-10.30 3691
6 EX-21 SUBSIDIARIES b45648anexv21.txt EX-21 341
7 EX-23 CONSENT OF KPMG LLP b45648anexv23.txt EX-23 1362
8 EX-99.1 RISK FACTORS b45648anexv99w1.txt EX-99.1 33409
9 EX-99.2 906 CERTIFICATION-GARO ARMEN b45648anexv99w2.txt EX-99.2 1170
10 EX-99.3 906 CERTIFICATION-JEFF CLARK b45648anexv99w3.txt EX-99.3 1137
11 COURTESY PDF b45648ane10vkxpdfy.pdf 10-K 795927
  Complete submission text file 0000950135-03-002018.txt   1579217
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 03621333
SIC: 2836 Biological Products, (No Diagnostic Substances)